The Cooper Companies, Inc. (LON:0I3I)

Market Cap	11.93B -24.5%
Revenue (ttm)	3.12B +5.1%
Net Income	285.44M -4.4%
EPS	1.42 -4.6%
Shares Out	n/a
PE Ratio	41.79
Forward PE	18.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120
Average Volume	405
Open	83.50
Previous Close	82.50
Day's Range	81.54 - 83.96
52-Week Range	61.00 - 93.61
Beta	1.03
RSI	52.93
Earnings Date	Mar 5, 2026

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1958
• Employees: 15,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I3I

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Financial numbers in USD